Guzick Named Dean of University of Rochester School of Medicine & Dentistry
Monday, October 20, 2003
On the recommendation of University of Rochester President Thomas H. Jackson and Senior Vice President and Vice Provost for Health Affairs Jay H. Stein, M.D., the Board of Trustees has approved the appointment of David S. Guzick, M.D., Ph.D., as the ninth dean of the University of Rochester School of Medicine and Dentistry.
Dr. Guzick succeeds Dean Edward M. Hundert who will become president of Case Western Reserve University in Cleveland, Ohio, in August. Dr. Guzick has served as the Henry A. Thiede professor and chair of the Department of Obstetrics and Gynecology at the University of Rochester School of Medicine and Dentistry since 1995, in addition to chief of service of Obstetrics and Gynecology at Strong Memorial Hospital and Highland Hospital.
“We’re very pleased to have Dr. Guzick join our roster of academic deans,” said President Jackson. “With a very distinguished career to date, he also has a keen ‘inside understanding’ of the medical school’s existing and potential strengths and we look forward to his contributions both to the School and University.”
Dr. Guzick came to Rochester from the University of Pittsburgh School of Medicine and Magee-Women’s Hospital where he served as professor of Obstetrics, Gynecology and Reproductive Science and director of the Division of Reproductive Endocrinology. He earned both his medical degree and Ph.D. from New York University as part of a National Institutes of Health scholarship. Following a residency in obstetrics and gynecology at The Johns Hopkins Hospital, he completed a fellowship in reproductive endocrinology at the University of Texas, Southwestern Medical School. Dr. Guzick is board-certified in obstetrics and gynecology and in reproductive endocrinology.
“The combination of David Guzick’s clinical, research and academic experience is perfectly suited for the challenge of continuing our growth and advancement as a world-class medical school,” said Dr. Stein. “His expertise as a department chair, clinician, and researcher combine to provide momentum we need to advance, especially with regard to the important field of clinical research. He’s well suited to further the progress made under the leadership of Dr. Hundert, and Lowell Goldsmith before him.”
“The medical school curriculum has undergone a tremendous transformation, complemented by the advancement of basic research, and we have many extraordinary areas of excellence in clinical research upon which to build,” Dr. Guzick said. “Education, research and patient care are inextricably intertwined. By developing our clinical programs, we will be better positioned to attract funding for clinical research which, in turn, will attract top talent to our faculty. That results in attracting the highest quality medical students and residents to our medical center. But the benefits extend beyond that. When you consider that a large percentage of the graduates of our residency programs remain in this community to practice medicine, enhancing the quality of the medical school and our residency programs has a significant impact on the quality of medical care provided and on the health of our community.”
“David Guzick is the perfect choice for dean,” added Dr. Hundert. “His expertise is exactly what is needed to continue building upon what we have developed, and to provide leadership for growth in important initiatives such as clinical research. I look forward to the next few months as we collaborate for a smooth transition.”
Dr. Guzick serves as an oral examiner for the American Board of Obstetrics and Gynecology. He was named by Good Housekeeping as one of American’s 400 Best Doctors for Women. He has published over 100 articles on a variety of topics in obstetrics and gynecology, infertility and reproductive endocrinology. He is a member of the American Gynecologic and Obstetric Society, the Society for Gynecologic Investigation, the Council of Chairs of Obstetrics and Gynecology, the American Board of Obstetrics and Gynecology, The Endocrine Society, the American Society for Reproductive Medicine, the Society of Reproductive Endocrinologists and the Society of Assisted Reproductive Technology.